arrow
C

Christoph Kreer

University of Cologne
H指数:22
被引数:2,209

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification of a potent V3 glycan site broadly neutralizing antibody targeting an N332gp120 glycan-independent epitope

靶向N332gp120非聚糖依赖性表位的有效V3聚糖位点广泛中和抗体的鉴定

2026-02-030
OAAI
ERBB2 signaling drives immune cell evasion and resistance against immunotherapy in small cell lung cancer

ERBB2信号驱动小细胞肺癌中的免疫细胞逃逸以及对免疫治疗的抵抗

2025-12-090
OA
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy

HIV-1精英中和者队列的表征分析揭示了一种靶向CD4bs的广谱中和抗体,可用于HIV-1的预防和治疗

2025-10-060
OA
Guiding Antiviral Cell Therapy Approaches with an Online Resource of Clinically Scored Epitopes, T-Cell Receptors, and B-Cell Receptors

通过临床评分表位、T细胞受体和B细胞受体的在线资源指导抗病毒细胞疗法研究

2025-09-010
OA
Dynamics and durability of HIV-1 neutralization are determined by viral replication
2023-11-132
OAAI
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer
IMMUNITY
IF26.3
2023-11-014
OAAI
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization
IMMUNITY
IF26.3
2022-02-0122
OA
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection
2021-07-2945
OAAI
Long-lived macrophage reprogramming drives spike protein-mediated inflammasome activation in COVID-19
2021-06-1696
OAAI
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV (vol 16, e1008560, 2020)
2021-03-010
OAAI
Repertoire characterization and validation of gB-specific human IgGs directly cloned from humanized mice vaccinated with dendritic cells and protected against HCMV
2020-07-1518
OAAI
Polyclonal and convergent antibody response to Ebola virus vaccine rVSV-ZEBOV

对埃博拉病毒疫苗rvsv-zebov的多克隆和收敛抗体反应

2019-10-0798
OAAI